+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Cancer Drugs Market Research Reports

From
From
Melanoma KOL Interview - US #2 - Product Thumbnail Image

Melanoma KOL Interview - US #2

  • Newsletter
  • March 2025
  • 12 Pages
  • United States
Skin Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Skin Cancer Treatment Drugs Markets in China

  • Report
  • September 2024
  • 231 Pages
  • China
From
Market Spotlight: Basal Cell Carcinoma (2020) - Product Thumbnail Image

Market Spotlight: Basal Cell Carcinoma (2020)

  • Report
  • March 2020
  • 33 Pages
  • Global
Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019 - Product Thumbnail Image

Nexavar (sorafenib; Bayer/Amgen) Drug Overview 2019

  • Report
  • September 2019
  • 28 Pages
  • Global
Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) Drug Overview 2019 - Product Thumbnail Image

Opdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 118 Pages
  • Global
Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019 - Product Thumbnail Image

Keytruda (pembrolizumab; Merck & Co) Drug Overview 2019

  • Drug Pipelines
  • September 2019
  • 141 Pages
  • Global
Bavencio (avelumab; Merck KGaA/Pfizer) Drug Overview 2019 - Product Thumbnail Image

Bavencio (avelumab; Merck KGaA/Pfizer) Drug Overview 2019

  • Drug Pipelines
  • March 2019
  • 86 Pages
  • Global
Tarceva - Product Thumbnail Image

Tarceva

  • Report
  • August 2018
  • 25 Pages
  • Global
From
Abraxane - Product Thumbnail Image

Abraxane

  • Report
  • August 2018
  • 48 Pages
  • Global
From
Iressa - Product Thumbnail Image

Iressa

  • Report
  • August 2018
  • 21 Pages
  • Global
From
alimta - API Insight, 2022 - Product Thumbnail Image

alimta - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Xeloda - API Insight, 2022 - Product Thumbnail Image

Xeloda - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Zelboraf - API Insight, 2022 - Product Thumbnail Image

Zelboraf - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Temodar - API Insight, 2022 - Product Thumbnail Image

Temodar - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Taxotere - API Insight, 2022 - Product Thumbnail Image

Taxotere - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Tarceva - API Insight, 2022 - Product Thumbnail Image

Tarceva - API Insight, 2022

  • Drug Pipelines
  • January 2022
  • 30 Pages
  • Global
From
Loading Indicator

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically. The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer. In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more